Clinical Trial Update: Pilot Study of Hemoglobin Based Oxygen Therapeutics in Elective Coronary Revascularization [Phase 2]

View source ↗

Summary

Phase 2 pilot study of hemoglobin-based oxygen therapeutics in elective coronary revascularization has completed, evaluating safety and potential efficacy signa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Myocardial Infarction
• Unstable Angina

Drugs mentioned

• Hemopure (HBOC-201)

Snippet

Sponsor: Biopure Corporation | Conditions: Angina Pectoris, Unstable Angina | Phase 2 | Status: COMPLETED